Human safety profile of tolrestat: An aldose reductase inhibitor
β Scribed by Steven Ryder; Brenda Sarokhan; David G. Shand; John F. Mullane
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 848 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The inhibitory effects of an aldose reductase inhibitor, sorbinil (Pfizer, NY), on cerebral glucose metabolism were investigated noninvasively in rat brain using 19F nuclear magnetic resonance (NMR) spectroscopy and 2-fluoro-2-deoxy-D-glucose (2-FDG). Sorbinil given orally in the daily recommended d
## Abstract An alternative synthesis of the lipophilic antifolate piritrexim (1) is outlined. Starting from ketone 2, treatment with phosphorus oxychloride and dimethylformamide gave the Ξ²βchlorocrotonaldehydes 3__E/Z__, which were reacted with cyanoacetamide (6) in the presence of sodium hydride t